1921
Volume 84, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

A patient presenting with an atypical manifestation of cutaneous leishmaniasis after travel to Cyprus was successfully treated with miltefosine. The K26 typing revealed a hitherto undescribed strain of the complex as the causing agent.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2011.10-0645
2011-04-05
2020-07-05
Loading full text...

Full text loading...

/deliver/fulltext/14761645/84/4/562.html?itemId=/content/journals/10.4269/ajtmh.2011.10-0645&mimeType=html&fmt=ahah

References

  1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581596.[Crossref]
    [Google Scholar]
  2. Gonzalez U, Pinart M, Reveiz L, Alvar J, 2008. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev CD005067.
    [Google Scholar]
  3. Blum J, Desjeux P, Schwartz E, Beck B, Hatz C, 2004. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53: 158166.[Crossref]
    [Google Scholar]
  4. Mondal S, Bhattacharya P, Ali N, 2010. Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther 8: 919944.[Crossref]
    [Google Scholar]
  5. Calvopina M, Gomez EA, Sindermann H, Cooper PJ, Hashiguchi Y, 2006. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. Am J Trop Med Hyg 75: 10741077.
    [Google Scholar]
  6. Mohebali M, Fotouhi A, Hooshmand B, Zarei Z, Akhoundi B, Rahnema A, Razaghian AR, Kabir MJ, Nadim A, 2007. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop 103: 3340.[Crossref]
    [Google Scholar]
  7. Soto J, Toledo JT, 2007. Oral miltefosine to treat new world cutaneous leishmaniasis. Lancet Infect Dis 7: 7.[Crossref]
    [Google Scholar]
  8. Tappe D, Muller A, Stich A, 2010. Resolution of cutaneous old world and new world leishmaniasis after oral miltefosine treatment. Am J Trop Med Hyg 82: 13.[Crossref]
    [Google Scholar]
  9. Faber WR, Wonders J, Jensema AJ, Chocholova E, Kager PA, 2009. Cutaneous leishmaniasis with lymphadenopathy due to Leishmania donovani . Clin Exp Dermatol 34: e196e198.[Crossref]
    [Google Scholar]
  10. Neub A, Krahl D, Stich A, Amon U, 2008. Cutaneous infection with Leishmania infantum in an infant treated successfully with miltefosine. J Dtsch Dermatol Ges 6: 10611064.[Crossref]
    [Google Scholar]
  11. van Eys GJ, Schoone GJ, Kroon NC, Ebeling SB, 1992. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol 51: 133142.[Crossref]
    [Google Scholar]
  12. Dujardin JC, Campino L, Canavate C, Dedet JP, Gradoni L, Soteriadou K, Mazeris A, Ozbel Y, Boelaert M, 2008. Spread of vector-borne diseases and neglect of leishmaniasis, Europe. Emerg Infect Dis 14: 10131018.[Crossref]
    [Google Scholar]
  13. Haralambous C, Antoniou M, Pratlong F, Dedet JP, Soteriadou K, 2008. Development of a molecular assay specific for the Leishmania donovani complex that discriminates L. donovani/Leishmania infantum zymodemes: a useful tool for typing MON-1. Diagn Microbiol Infect Dis 60: 3342.[Crossref]
    [Google Scholar]
  14. Nicholas KB, Nicholas HB Jr., Deerfield DW II, 1997. GeneDoc: analysis and visualization of genetic variation. Embnet News 4: 14.
    [Google Scholar]
  15. Antinori S, Gianelli E, Calattini S, Longhi E, Gramiccia M, Corbellino M, 2005. Cutaneous leishmaniasis: an increasing threat for travellers. Clin Microbiol Infect 11: 343346.[Crossref]
    [Google Scholar]
  16. Alam MZ, Haralambous C, Kuhls K, Gouzelou E, Sgouras D, Soteriadou K, Schnur L, Pratlong F, Schonian G, 2009. The paraphyletic composition of Leishmania donovani zymodeme MON-37 revealed by multilocus microsatellite typing. Microbes Infect 11: 707715.[Crossref]
    [Google Scholar]
  17. Mazeris A, Soteriadou K, Dedet JP, Haralambous C, Tsatsaris A, Moschandreas J, Messaritakis I, Christodoulou V, Papadopoulos B, Ivovic V, Pratlong F, Loucaides F, Antoniou M, 2010. Leishmaniases and the Cyprus paradox. Am J Trop Med Hyg 82: 441448.[Crossref]
    [Google Scholar]
  18. Antoniou M, Haralambous C, Mazeris A, Pratlong F, Dedet JP, Soteriadou K, 2008. Leishmania donovani leishmaniasis in Cyprus. Lancet Infect Dis 8: 67.[Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.10-0645
Loading
/content/journals/10.4269/ajtmh.2011.10-0645
Loading

Data & Media loading...

  • Received : 15 Nov 2010
  • Accepted : 01 Feb 2011
  • Published online : 05 Apr 2011
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error